A bipartisan bill introduced Tuesday would establish federal rules for hemp-derived products and preserve access to qualifying CBD products as an alternative to federal restrictions scheduled to take effect Dec. 11.
U.S. Sens. Tim Sheehy, R-Montana, and Amy Klobuchar, D-Minnesota, introduced the Hemp Guardrails Act, which would replace the upcoming federal limits on hemp-derived THC products with a regulatory framework covering product safety, manufacturing and sales.
The proposal comes as hemp businesses face a Dec. 11 deadline, when a federal limit of 0.4 milligrams of total THC per container is set to take effect, potentially removing a wide range of hemp-derived products from the legal market.
What would the Hemp Guardrails Act do?
The senators say the bill would protect consumers, children, farmers and businesses while preserving access to legally produced hemp products that would otherwise be prohibited under the upcoming federal restrictions.
The legislation would also expand federal oversight of the hemp industry while allowing states to maintain stricter regulations.
“Minnesota is a national leader in hemp, and our state has shown that we can protect kids and support responsible hemp businesses,” Klobuchar said in a statement announcing the legislation.
“But a looming federal ban on hemp products is threatening farmers, brewers, small businesses, and consumers across Minnesota and the country.”
“This new bill with Senator Sheehy would keep safe hemp products on store shelves, protect consumers from dangerous products, and ensure that farmers and small businesses can continue to operate, grow, and create jobs.”
According to a summary released by Sheehy’s office, the bill would:
- Prohibit the sale, possession and consumption of consumable hemp products by individuals younger than 21.
- Direct the Food and Drug Administration to establish strict child-resistant packaging, labeling, manufacturing and testing requirements for hemp products.
- Prohibit raw floral hemp material, smokable hemp flower and hemp prerolls intended for inhalation from entering interstate commerce.
- Ban delta-8 THC, delta-10 THC and THC-O products and restrict the manufacturing or synthesis of those compounds outside the hemp plant.
- Maintain restrictions on synthetic cannabinoids that do not occur naturally in hemp.
- Authorize the FDA to inspect facilities, seize adulterated or misbranded products and enforce federal requirements for consumable hemp products entering interstate commerce.
- Establish federal oversight by creating categories for hemp-derived cannabinoid products and dietary supplements under the Federal Food, Drug and Cosmetic Act.
- Increase the allowable THC threshold for hemp cultivation from 0.3% to 1% total THC on a dry-weight basis.
- Require consumable hemp products entering interstate commerce to be cultivated, processed, finished and packaged in the United States.
- Prohibit misleading packaging and marketing targeting children while requiring appropriate health warnings.
The proposal would also direct federal regulators to develop manufacturing, testing and labeling rules within 180 days of enactment.
Industry leaders back federal hemp regulations
“We’re taking a commonsense approach to this issue,” Sheehy said in a statement. “Our bill will put every bad actor in the hemp space out of business and keep intoxicating products out of the hands of children.
“It will also stop Congress from turning the farmers, veterans, and cancer patients who rely on these products into criminals overnight.”
The proposal has also drawn support from hemp businesses seeking to preserve access to CBD products while establishing clearer federal safety standards.
Bill Morachnick, CEO of Colorado-based hemp CBD firm Charlotte’s Web, said now is the time to get hemp policy right.
“Consumers should not pay the price for an industry fight over market share,” Morachnick said in a statement. “Senators Sheehy and Klobuchar’s proposal gives Congress a path forward: set the highest standards for safety, quality, and accountability, preserve responsible access, and hold all of us to them. Charlotte’s Web is ready.”
Republican lawmakers oppose delaying hemp restrictions
But the proposal faces opposition from Republican lawmakers who argue that allowing intoxicating hemp products to remain on the market would undermine consumer protections.
U.S. Sen. Ted Budd, R-North Carolina, said he would oppose any year-end government funding package that delays the upcoming restrictions or establishes a regulatory framework for the products.
“I will not support any year-end package that extends, delays, or builds a regulatory framework around products that fuel addiction, endanger our children, and weaken our workforce,” Budd said in a post on X.
U.S. Sen. Pete Ricketts, R-Nebraska, has also opposed delaying the restrictions, arguing in a Nov. 12 opinion piece that Congress should close what he described as a loophole allowing unregulated intoxicating hemp products to reach consumers.
The opposition could complicate efforts to advance the Hemp Guardrails Act before Dec. 11, when the existing federal restrictions are scheduled to take effect.
Medical Disclaimer:
The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.

